Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-029586
Filing Date
2021-07-22
Accepted
2021-07-22 21:00:46
Documents
2
Period of Report
2021-07-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2806
2 EX-24 DOCUMENT attachment1.htm EX-24 3734
  Complete submission text file 0000899243-21-029586.txt   7873
Mailing Address 3061 ZANKER RD SAN JOSE CA 95134
Business Address
GUGGENHIME ANDREW (Reporting) CIK: 0001230724 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40631 | Film No.: 211108865

Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Issuer) CIK: 0001619856 (see all company filings)

EIN.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)